VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,598 | -96.6% | 1,409 | -95.0% | 0.00% | -100.0% |
| Q2 2023 | $460,202 | -19.3% | 28,390 | -17.2% | 0.00% | 0.0% |
| Q1 2023 | $570,580 | +57.4% | 34,269 | -11.2% | 0.00% | 0.0% |
| Q4 2022 | $362,558 | +1150.2% | 38,570 | +727.3% | 0.00% | – |
| Q3 2021 | $29,000 | -3.3% | 4,662 | -5.9% | 0.00% | – |
| Q2 2021 | $30,000 | -6.2% | 4,953 | -1.0% | 0.00% | – |
| Q1 2021 | $32,000 | +300.0% | 5,002 | +242.8% | 0.00% | – |
| Q4 2020 | $8,000 | -65.2% | 1,459 | -62.8% | 0.00% | – |
| Q3 2020 | $23,000 | -23.3% | 3,925 | -5.1% | 0.00% | – |
| Q2 2020 | $30,000 | +50.0% | 4,135 | -2.5% | 0.00% | – |
| Q1 2020 | $20,000 | -37.5% | 4,243 | +5.2% | 0.00% | – |
| Q4 2019 | $32,000 | +18.5% | 4,033 | +1.2% | 0.00% | – |
| Q3 2019 | $27,000 | -20.6% | 3,987 | -2.6% | 0.00% | – |
| Q2 2019 | $34,000 | -17.1% | 4,095 | -1.3% | 0.00% | – |
| Q1 2019 | $41,000 | – | 4,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
| Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
| Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
| Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
| Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
| DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
| 5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
| Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |